Open AccessP837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST‐ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST‐ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN
Author(s) -
Vallejo C.,
García I.,
Sanchez Guijo F.,
Cuesta M.,
Solano C.,
Sampol A.,
Torrado T.,
Vendranas M.,
Marigil M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846232.58961.88
Subject(s) - cytopenia , medicine , neutropenia , anemia , eltrombopag , hematopoietic stem cell transplantation , clinical endpoint , gastroenterology , adverse effect , surgery , clinical trial , transplantation , bone marrow , platelet , toxicity , immune thrombocytopenia